IRWD Q3 2018 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$603M

Q3 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$66M-24.3% YoY

Gross Profit

$61M93.0% margin

Operating Income

-$169M-257.4% margin

Net Income

-$174M-265.4% margin

EPS (Diluted)

$-1.14

QoQ Revenue Growth

-19.0%

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$29M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$417M

Total Liabilities

$614M

Stockholders' Equity

-$197M

Cash & Equivalents

$142M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$66M	$87M	-24.3%
Gross Profit	$61M	$81M	-24.4%
Operating Income	-$169M	-$19M	-770.1%
Net Income	-$174M	-$32M	-439.8%

Revenue Segments

Active Pharmaceutical Ingredient

$10M100%

Geographic Segments

J

$10M100%